↓ Skip to main content

Placebo Adherence and Mortality in the Heart and Estrogen/Progestin Replacement Study

Overview of attention for article published in American Journal of Medicine, August 2012
Altmetric Badge

Mentioned by

twitter
3 X users

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Placebo Adherence and Mortality in the Heart and Estrogen/Progestin Replacement Study
Published in
American Journal of Medicine, August 2012
DOI 10.1016/j.amjmed.2012.02.014
Pubmed ID
Authors
Abstract

Analyses from double-blind randomized trials have reported lower mortality among participants who were more adherent to placebo compared with those who were less adherent. We explored this phenomenon by analyzing data from the placebo arm of the Heart and Estrogen/Progestin Replacement Study (HERS), a randomized, double-blind, placebo-controlled trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Our primary aim was to measure and explain the association between adherence to placebo and total mortality among the placebo-allocated participants in the HERS. Secondary aims included assessment of the association between placebo adherence and cause-specific morbidity and mortality.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Colombia 1 2%
Unknown 43 98%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 10 23%
Student > Ph. D. Student 7 16%
Student > Master 5 11%
Other 4 9%
Lecturer 2 5%
Other 6 14%
Unknown 10 23%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 16 36%
Nursing and Health Professions 4 9%
Psychology 4 9%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Biochemistry, Genetics and Molecular Biology 2 5%
Other 6 14%
Unknown 9 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 December 2019.
All research outputs
#24,936,481
of 34,593,328 outputs
Outputs from American Journal of Medicine
#8,781
of 10,693 outputs
Outputs of similar age
#159,098
of 215,189 outputs
Outputs of similar age from American Journal of Medicine
#53
of 73 outputs
Altmetric has tracked 34,593,328 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 10,693 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.1. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 215,189 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 73 others from the same source and published within six weeks on either side of this one. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.